Regeneron Pharmaceuticals Inc (WBO:REGN)
€ 910.2 5.8 (0.64%) Market Cap: 99.67 Bil Enterprise Value: 92.44 Bil PE Ratio: 28.90 PB Ratio: 3.99 GF Score: 77/100

Regeneron Pharmaceuticals Inc at Jefferies Virtual London Healthcare Conference Transcript

Nov 17, 2020 / 12:20PM GMT
Release Date Price: €457.45 (-3.67%)
Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

Welcome, everyone, to the Jefferies London Virtual Health Care Conference. My name is Biren Amin. I'm one of the biotech analysts here at Jefferies. I'd like to welcome Regeneron and their Chief Financial Officer, Robert Landry; as well as Head of Investor Relations, Justin Holko. So before -- this will be a fireside chat format. So before we get started with the Q&A, I believe you have forward-looking statements that you'd like to read, and then maybe we can get started. But welcome, Bob and Justin, and thanks for attending our conference.

Robert E. Landry
Regeneron Pharmaceuticals, Inc. - Executive VP of Finance & CFO

Sure, Biren. Thanks very much for the invite. This is a conference we've been at the last couple of years and have always enjoyed attending that. And to everyone on the virtual environment, good morning and good afternoon to everybody.

So as Biren said before we begin, let me remind you that today, there will be remarks on this webcast,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot